Basis of antifibrinolytic therapy.
D015119:Aminocaproic Acid / Q000494:pharmacology; D000933:Antifibrinolytic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007611:Aprotinin / Q000494:pharmacology; D002364:Caseins / Q000378:metabolism; D005337:Fibrin / Q000502:physiology; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects; D006470:Hemorrhage / Q000097:blood; D006801:Humans; D014148:Tranexamic Acid / Q000494:pharmacology
D000933:Antifibrinolytic Agents; D002364:Caseins; D014148:Tranexamic Acid; D005337:Fibrin; D007611:Aprotinin; D005341:Fibrinolysin; D015119:Aminocaproic Acid